SC
GILD icon

Sapient Capital’s Gilead Sciences GILD Stock Holding History

Sapient Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Buy
165,115
+2,289
+1% +$302K 0.27% 53
2026
Q1 		$22.7M Sell
162,826
-10,520
-6% -$1.47M 0.34% 39
2025
Q4 		$21.3M Sell
173,346
-1,732
-1% -$210K 0.3% 54
2025
Q3 		$19.7M Sell
175,078
-8,077
-4% -$918K 0.3% 55
2025
Q2 		$20.3M Sell
183,155
-2,205
-1% -$235K 0.36% 52
2025
Q1 		$20.8M Buy
185,360
+182,774
+7,068% +$18.9M 0.41% 53
2024
Q4 		$239K Buy
2,586
+44
+2% +$3.96K ﹤0.01% 338
2024
Q3 		$213K Buy
+2,542
New +$194K ﹤0.01% 365
2024
Q1 		– Sell
-3,086
Closed -$250K – 378
2023
Q4 		$250K Buy
+3,086
New +$240K 0.01% 332

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Sapient Capital's GILD Position: Q2 2026 in Review

Sapient Capital increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $302K and bringing the position to 165,115 shares worth $20.9M. The position accounts for 0.27% of the portfolio, ranked #53.

Sapient Capital first reported a position in GILD in Q4 2023 and has held it in 9 quarters since. The position peaked at $22.7M in Q1 2026. 425 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sapient Capital held 165,115 shares of Gilead Sciences worth $20.9M as of Q2 2026.
  • Sapient Capital bought 2,289 Gilead Sciences shares in Q2 2026, an estimated $302K.
  • Gilead Sciences made up 0.27% of Sapient Capital's portfolio in Q2 2026, its #53 holding.
  • Sapient Capital first reported a position in Gilead Sciences in Q4 2023 and has held it in 9 quarters since.
  • Sapient Capital's Gilead Sciences position peaked at $22.7M in Q1 2026.
  • 425 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.